(Q42906268)

10 November 2017

title

Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine (English)

1 reference

10 November 2017

1 reference

Koichi Hayashi

1

1 reference

10 November 2017

Takao Saruta

2

1 reference

10 November 2017

Yoshio Goto

3

1 reference

10 November 2017

Masao Ishii

4

1 reference

10 November 2017

JATOS Study Group

5

1 reference

10 November 2017

publication date

16 September 2010

1 reference

10 November 2017

published in

Hypertension Research

1 reference

10 November 2017

volume

33

1 reference

10 November 2017

issue

11

1 reference

10 November 2017

page(s)

1211-1220

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.162

10 November 2017

exact match

0 references

cites work

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Revised equations for estimated GFR from serum creatinine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Nongenomic vascular action of aldosterone in the glomerular microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Ca2+ channel subtypes and pharmacology in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Calcium antagonists: Do they equally protect against kidney injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Proteinuria and the risk of developing end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Extended prognostic value of urinary albumin excretion for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Kidney function and mortality among patients with left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Rapid kidney function decline and mortality risk in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): protocol, patient characteristics, and blood pressure during the first 12 months

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Disparate effects of calcium antagonists on renal microcirculation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Identifiers

DOI

10.1038/HR.2010.162

1 reference

Dimensions Publication ID

10 November 2017

1033343666

0 references

1 reference